Back
Nuveen Real Estate Income Fund. Vs. Axsome Therapeutics, Inc. Industry Stock Comparison
Buy
67
JRS
Nuveen Real Estate Income Fund.
Last Price:
$7.65
Seasonality Move:
1.27%
Buy
75
AXSM
Axsome Therapeutics, Inc.
Last Price:
$182.74
Seasonality Move:
22.61%
Buy
67
Nuveen Real Estate Income Fund. (JRS)
is a Buy
Is Nuveen Real Estate Income Fund. a Buy, Sell or Hold?
-
The current Nuveen Real Estate Income Fund. [JRS] share price is $7.66. The Score for JRS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
JRS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Axsome Therapeutics, Inc. (AXSM)
is a Buy
Is Axsome Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Axsome Therapeutics, Inc. [AXSM] share price is $182.64. The Score for AXSM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
AXSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JRS Stock Price Chart
What is Nuveen Real Estate Income Fund.'s stock price today?
-
The Nuveen Real Estate Income Fund. share price today is $7.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JRS is experiencing slight selling pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics, Inc.'s stock price today?
-
The Axsome Therapeutics, Inc. share price today is $182.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXSM is experiencing buying pressure, which is a positive indicator for future bullish movement.
JRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 45.71 | Sell |
| Chaikin Money Flow: | -35678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.6 - 7.82) | Sell |
| Bollinger Bands (100): | (7.73 - 8.13) | Sell |
AXSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.73 | Buy |
| Relative Strength Index (14 RSI): | 79.74 | Buy |
| Chaikin Money Flow: | 2638953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.49 - 157.75) | Buy |
| Bollinger Bands (100): | (116.98 - 146.48) | Buy |
JRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.62 | Buy |
| 20-day SMA: | 7.67 | Sell |
| 50-day SMA: | 7.83 | Sell |
| 200-day SMA: | 7.87 | Sell |
| 8-day EMA: | 7.64 | Buy |
| 20-day EMA: | 7.68 | Sell |
| 50-day EMA: | 7.79 | Sell |
| 200-day EMA: | 7.96 | Sell |
AXSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.17 | Buy |
| 20-day SMA: | 151.07 | Buy |
| 50-day SMA: | 144.32 | Buy |
| 200-day SMA: | 119.69 | Buy |
| 8-day EMA: | 157.9 | Buy |
| 20-day EMA: | 152.42 | Buy |
| 50-day EMA: | 144.44 | Buy |
| 200-day EMA: | 123.72 | Buy |
Nuveen Real Estate Income Fund. Earnings Growth & JRS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics, Inc. Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.11 per share, and an increase next year of $5.92 per share.
Nuveen Real Estate Income Fund. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axsome Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||